Joon-ho Sheen
Molecular Biology · 2006
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 12 citations into it; #12,715 of 17,773 by trust here, #6,535 by citations
Whom Joon-ho Sheen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Joon-ho Sheen overall
Papers from Joon-ho Sheen's perspective
Ordered by how strongly the researchers Joon-ho Sheen trusts endorse each paper. Same corpus, a different order for every researcher.
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
- mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes* (Journal of Biological Chemistry)
- mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)
- Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (Current Biology)
- Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor (Nature Medicine)
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (Nature Medicine)
- Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
- Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity (Nature)
- Growing roles for the mTOR pathway. (Current Opinion in Cell Biology)
- mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. (Cancer Research)
Their papers
- Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. (2006) — 2,823 citations